| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Moss AA et al. | Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. | 1978 | AJR Am J Roentgenol | pmid:101028 |
| Stickney RH et al. | Chlamydia trachomatis: a cause of an infantile pneumonia syndrome. | 1978 | AJR Am J Roentgenol | pmid:101061 |
| Lauenstein TC et al. | Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. | 2003 | AJR Am J Roentgenol | pmid:12704042 |
| Van Herwaarden MA et al. | The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. | 2000 | Aliment. Pharmacol. Ther. | pmid:10759625 |
| Ramirez B and Richter JE | Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. | 1993 | Aliment. Pharmacol. Ther. | pmid:8094981 |
| Catnach SM et al. | Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man. | 1993 | Aliment. Pharmacol. Ther. | pmid:8439638 |
| Russo A et al. | Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. | 2004 | Aliment. Pharmacol. Ther. | pmid:15274670 |
| Verhagen MA et al. | Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. | 1997 | Aliment. Pharmacol. Ther. | pmid:9663833 |
| Haans JJ and Masclee AA | Review article: The diagnosis and management of gastroparesis. | 2007 | Aliment. Pharmacol. Ther. | pmid:18081647 |
| Bai Y et al. | Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. | 2011 | Aliment. Pharmacol. Ther. | pmid:21615438 |
| Talley NJ et al. | Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. | 2000 | Aliment. Pharmacol. Ther. | pmid:11121915 |
| Emmanuel AV et al. | Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. | 2004 | Aliment. Pharmacol. Ther. | pmid:15023171 |
| Netzer P et al. | Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease. | 2002 | Aliment. Pharmacol. Ther. | pmid:12182748 |
| Athanasakis E et al. | Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects. | 2002 | Aliment. Pharmacol. Ther. | pmid:12182757 |
| McCallum RW and Cynshi O | Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. | 2007 | Aliment. Pharmacol. Ther. | pmid:17894654 |
| Chen CL et al. | Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. | 2002 | Aliment. Pharmacol. Ther. | pmid:11929393 |
| Winstead NS and Wilcox CM | Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost-effectiveness analysis. | 2007 | Aliment. Pharmacol. Ther. | pmid:17848180 |
| Bell GD et al. | Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. | 1992 | Aliment. Pharmacol. Ther. | pmid:1486161 |
| Brand RM et al. | Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. | 1997 | Aliment. Pharmacol. Ther. | pmid:9218087 |
| Annese V et al. | Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. | 1997 | Aliment. Pharmacol. Ther. | pmid:9218089 |
| van Erpecum KJ et al. | Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. | 2000 | Aliment. Pharmacol. Ther. | pmid:10903008 |
| Chiba T et al. | Motilides accelerate regional gastrointestinal transit in the dog. | 2000 | Aliment. Pharmacol. Ther. | pmid:10886053 |
| Minocha A et al. | Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study. | 1995 | Aliment. Pharmacol. Ther. | pmid:8580273 |
| Landry C et al. | Could oral erythromycin optimize high energy continuous enteral nutrition? | 1996 | Aliment. Pharmacol. Ther. | pmid:8971296 |
| Ehrenpreis ED et al. | Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis. | 1998 | Aliment. Pharmacol. Ther. | pmid:9690728 |
| Jameson JS et al. | Oral or intravenous erythromycin has no effect on human distal colonic motility. | 1992 | Aliment. Pharmacol. Ther. | pmid:1420750 |
| Osato MS et al. | Comparative efficacy of new investigational agents against Helicobacter pylori. | 2001 | Aliment. Pharmacol. Ther. | pmid:11284777 |
| Medhus AW et al. | Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. | 2000 | Aliment. Pharmacol. Ther. | pmid:10651665 |
| Curry JI et al. | Review article: erythromycin as a prokinetic agent in infants and children. | 2001 | Aliment. Pharmacol. Ther. | pmid:11328252 |
| Kendall BJ et al. | The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. | 1997 | Aliment. Pharmacol. Ther. | pmid:9146779 |
| Boecxstaens V et al. | Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. | 2011 | Aliment. Pharmacol. Ther. | pmid:21517922 |
| Laine L et al. | Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori. | 1996 | Aliment. Pharmacol. Ther. | pmid:8791949 |
| Wehrmann T et al. | Effect of erythromycin on human biliary motility. | 1996 | Aliment. Pharmacol. Ther. | pmid:8791972 |
| San Pedro de Saenz B et al. | FDE to macrolides. | 2002 | Allergy | pmid:11991294 |
| Florido Lopez JF et al. | Fixed eruption due to erythromycin. A case report. | 1991 | Allergy | pmid:1826819 |
| Miller KE | Diagnosis and treatment of Chlamydia trachomatis infection. | 2006 | Am Fam Physician | pmid:16669564 |
| Constantine PA | Antibiotic therapy and serum digoxin toxicity. | 1998 | Am Fam Physician | pmid:9531908 |
| Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement. | 2012 | Am Fam Physician | pmid:22335221 | |
| Tan HH | Antibacterial therapy for acne: a guide to selection and use of systemic agents. | 2003 | Am J Clin Dermatol | pmid:12688836 |
| Taylor GA and Shalita AR | Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review. | 2004 | Am J Clin Dermatol | pmid:15301572 |
| Ferguson DL et al. | Lichenoid lymphocytic vasculitis with a high component of histiocytes. Histogenetic implications in a specified clinical setting. | 1989 | Am J Dermatopathol | pmid:2729528 |
| Rosen RA | The use of antibiotics in the initial management of recent dog-bite wounds. | 1985 | Am J Emerg Med | pmid:3970747 |
| Altieri M et al. | Antibiotic prophylaxis in intraoral wounds. | 1986 | Am J Emerg Med | pmid:3096345 |
| Paris DG et al. | Torsades de pointes induced by erythromycin and terfenadine. | 1994 | Am J Emerg Med | pmid:7945604 |
| Traub SJ et al. | Use of pharmaceutical promotility agents in the treatment of body packers. | 2003 | Am J Emerg Med | pmid:14574669 |
| Parker DL et al. | Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin. | 2010 | Am J Health Syst Pharm | pmid:20044367 |
| Howard KB et al. | Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis. | 1999 | Am J Health Syst Pharm | pmid:10478989 |
| Erythromycin resistance in Finland declines after reduction in macrolide use. | 1997 | Am J Health Syst Pharm | pmid:9359947 | |
| Lestico MR and Smith AD | Stevens-Johnson syndrome following erythromycin administration. | 1995 | Am J Health Syst Pharm | pmid:8528839 |
| Horn JR | Analysis of purported erythromycin-warfarin interaction. | 2010 | Am J Health Syst Pharm | pmid:20516463 |
Erythromycin C
Erythromycin C is a lipid of Polyketides (PK) class.
Cross Reference
